Two Sigma Advisers’s CME Group CME Stock Holding History

Two Sigma Advisers’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-4,000	Closed	-$320K	–	2463
2014 Q3	$320K	Sell	4,000 -7,000	-64%	-$528K	﹤0.01%	1825
2014 Q2	$780K	Buy	+11,000	New	+$774K	0.01%	1341
2014 Q1	–	Sell	-5,000	Closed	-$392K	–	2298
2013 Q4	$392K	Buy	+5,000	New	+$391K	﹤0.01%	1746
2013 Q3	–	Sell	-4,000	Closed	-$304K	–	2117
2013 Q2	$304K	Buy	+4,000	New	+$262K	﹤0.01%	1710

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Two Sigma Advisers's CME Position: Q1 2026 in Review

Two Sigma Advisers sold out of CME Group (CME) in Q1 2026, closing a stake of 462,820 shares — an estimated $126M sold.

Two Sigma Advisers first reported a position in CME in Q3 2013 and held it in 34 quarters. The position peaked at $530M in Q1 2025. 1,803 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Two Sigma Advisers reported no remaining CME Group position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 462,820 CME Group shares in Q1 2026, an estimated $126M.
Two Sigma Advisers first reported a position in CME Group in Q3 2013 and held it in 34 quarters.
Two Sigma Advisers's CME Group position peaked at $530M in Q1 2025.
1,803 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.